相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unique protein interaction networks define the chromatin remodelling module of the NuRD complex
Mehdi Sharifi Tabar et al.
FEBS JOURNAL (2022)
Drug discovery in the era of cryo-electron microscopy
Michael J. Robertson et al.
TRENDS IN BIOCHEMICAL SCIENCES (2022)
The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions
Rose Oughtred et al.
PROTEIN SCIENCE (2021)
Structure-function relationships explain CTCF zinc finger mutation phenotypes in cancer
Charles G. Bailey et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Mass spectrometry-based protein-protein interaction networks for the study of human diseases
Alicia L. Richards et al.
MOLECULAR SYSTEMS BIOLOGY (2021)
Deciphering molecular interactions by proximity labeling
Wei Qin et al.
NATURE METHODS (2021)
PINA 3.0: mining cancer interactome
Yang Du et al.
NUCLEIC ACIDS RESEARCH (2021)
Nuclear Her2 contributes to paclitaxel resistance in breast cancer cells
Bo Luo et al.
ANTI-CANCER DRUGS (2021)
Comprehensive characterization of protein-protein interactions perturbed by disease mutations
Feixiong Cheng et al.
NATURE GENETICS (2021)
Trends in peptide drug discovery
Markus Muttenthaler et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Late adverse effects and quality of life in survivors of testicular germ cell tumour
Michal Chovanec et al.
NATURE REVIEWS UROLOGY (2021)
STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma
Didier Surdez et al.
CANCER CELL (2021)
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome
Edward L. Huttlin et al.
CELL (2021)
A proximity-dependent biotinylation map of a human cell
Christopher D. Go et al.
NATURE (2021)
Proximity labeling: an emerging tool for probing in planta molecular interactions
Xinxin Yang et al.
PLANT COMMUNICATIONS (2021)
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors
Caitlin M. O'Connor et al.
ONCOGENE (2020)
Proteogenomic Characterization of Endometrial Carcinoma
Yongchao Dou et al.
CELL (2020)
To Cleave or Not To Cleave in XL-MS?
B. Steigenberger et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2020)
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Esther Rheinbay et al.
NATURE (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
Bernardo Rodriguez-Martin et al.
NATURE GENETICS (2020)
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
Kadir C. Akdemir et al.
NATURE GENETICS (2020)
Biophysical prediction of protein-peptide interactions and signaling networks using machine learning
Joseph M. Cunningham et al.
NATURE METHODS (2020)
Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles
Helen H. N. Yan et al.
GUT (2020)
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Sha-Sha Cheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
Camilla Calandrini et al.
NATURE COMMUNICATIONS (2020)
Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers
Bing He et al.
SCIENCE ADVANCES (2020)
Integrating evolutionary dynamics into cancer therapy
Robert A. Gatenby et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Fragment-based screening sees the light
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
A high-stringency blueprint of the human proteome
Subash Adhikari et al.
NATURE COMMUNICATIONS (2020)
The Nucleosome Remodeling and Deacetylase Complex Has an Asymmetric, Dynamic, and Modular Architecture
Jason K. K. Low et al.
CELL REPORTS (2020)
Cryo-EM as a powerful tool for drug discovery
John H. Van Drie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials
Haiying Lu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Applications of organoids for cancer biology and precision medicine
Yuan-Hung Lo et al.
NATURE CANCER (2020)
Human gastric cancer modelling using organoids
Therese Seidlitz et al.
GUT (2019)
Chemical cross-linking with mass spectrometry: a tool for systems structural biology
Juan D. Chavez et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
The stoichiometry and interactome of the Nucleosome Remodeling and Deacetylase (NuRD) complex are conserved across multiple cell lines
Mehdi Sharifi Tabar et al.
FEBS JOURNAL (2019)
Mouse and human urothelial cancer organoids: A tool for bladder cancer research
Jasper Mullenders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Andy Chi-Lung Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
Luca Gambini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
Oded Kopper et al.
NATURE MEDICINE (2019)
mCSM-PPI2: predicting the effects of mutations on protein-protein interactions
Carlos H. M. Rodrigues et al.
NUCLEIC ACIDS RESEARCH (2019)
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy
Else Driehuis et al.
CANCER DISCOVERY (2019)
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Xiaotian Yuan et al.
ONCOGENE (2019)
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments
Miroslava Didiasova et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
RNA Interactions Are Essential for CTCF-Mediated Genome Organization
Ricardo Saldana-Meyer et al.
MOLECULAR CELL (2019)
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells
David N. Debruyne et al.
NATURE (2019)
Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening
Matteo Boretto et al.
NATURE CELL BIOLOGY (2019)
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer
Sahar Nissim et al.
NATURE GENETICS (2019)
A rectal cancer organoid platform to study individual responses to chemoradiation
Karuna Ganesh et al.
NATURE MEDICINE (2019)
Pancreatic cancer organoids recapitulate disease and allow personalized drug screening
Else Driehuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
An Organoid-Based Preclinical Model of Human Gastric Cancer
Nina G. Steele et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD•Yap Protein-Protein Interaction
Khuchtumur Bum-Erdene et al.
CELL CHEMICAL BIOLOGY (2019)
Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells
Takashi Kijima et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp9O-Cdc37 interaction
Xiangling Chen et al.
CANCER LETTERS (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey et al.
CELL (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression
Takashi Seino et al.
CELL STEM CELL (2018)
Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area
Xu Ran et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders
Siwei Chen et al.
NATURE GENETICS (2018)
Cryo-EM in drug discovery: achievements, limitations and prospects
Jean-Paul Renaud et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers
Yu Amanda Guo et al.
NATURE COMMUNICATIONS (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis
Kosaku Nanki et al.
CELL (2018)
Efficient proximity labeling in living cells and organisms with TurboID
Tess C. Branon et al.
NATURE BIOTECHNOLOGY (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability
Hema Adhikari et al.
NATURE COMMUNICATIONS (2018)
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics
Xiaodun Li et al.
NATURE COMMUNICATIONS (2018)
Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network
Manon Eckhardt et al.
CANCER DISCOVERY (2018)
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Sandro Nuciforo et al.
CELL REPORTS (2018)
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
Helen H. N. Yang et al.
CELL STEM CELL (2018)
Cross-linking mass spectrometry: methods and applications in structural, molecular and systems biology
Francis J. O'Reilly et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Protein-Protein Interactions: Emerging Oncotargets in the RAS-ERK Pathway
Rocio Garcia-Gomez et al.
TRENDS IN CANCER (2018)
HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networks
Gregorio Alanis-Lobato et al.
NUCLEIC ACIDS RESEARCH (2017)
Refinement of the subunit interaction network within the nucleosome remodelling and deacetylase (NuRD) complex
Mario Torrado et al.
FEBS JOURNAL (2017)
Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth
Bo Ram Kim et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc
A. A. Ivanov et al.
ONCOGENE (2017)
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies (vol 8, 14356, 2017)
Zenggang Li et al.
NATURE COMMUNICATIONS (2017)
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies
Zenggang Li et al.
NATURE COMMUNICATIONS (2017)
Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer
Alba Cristobal et al.
CELL REPORTS (2017)
Modulating Protein-Protein Interactions of the Mitotic Polo-like Kinases to Target Mutant KRAS
Ana J. Narvaez et al.
CELL CHEMICAL BIOLOGY (2017)
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
Andrew Goodspeed et al.
MOLECULAR CANCER RESEARCH (2016)
Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth
Dorien Haesen et al.
CANCER RESEARCH (2016)
Modeling Development and Disease with Organoids
Hans Clevers
CELL (2016)
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
Masayuki Fujii et al.
CELL STEM CELL (2016)
Replication fork stability confers chemoresistance in BRCA-deficient cells
Arnab Ray Chaudhuri et al.
NATURE (2016)
Mass-spectrometric exploration of proteome structure and function
Ruedi Aebersold et al.
NATURE (2016)
Pioneering apoptosis-targeted cancer drug poised for FDA approval
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2016)
Twenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
The MTA1 subunit of the nucleosome remodeling and deacetylase complex can recruit two copies of RBBP4/7
Jason W. Schmidberger et al.
PROTEIN SCIENCE (2016)
Activation of proto-oncogenes by disruption of chromosome neighborhoods
Denes Hnisz et al.
SCIENCE (2016)
Crosslinking and Mass Spectrometry: An Integrated Technology to Understand the Structure and Function of Molecular Machines
Alexander Leitner et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
High cell-surface density of HER2 deforms cell membranes
Inhee Chung et al.
NATURE COMMUNICATIONS (2016)
Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders
Nidhi Sahni et al.
CELL (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
Modulating protein-protein interactions: the potential of peptides
Laura Nevola et al.
CHEMICAL COMMUNICATIONS (2015)
Discovery of Chemical Inhibitors of Human Bromodomains
Guangtao Zhang et al.
CHEMICAL REVIEWS (2015)
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
Josh Lewis Stern et al.
GENES & DEVELOPMENT (2015)
CTCF/cohesin-binding sites are frequently mutated in cancer
Riku Katainen et al.
NATURE GENETICS (2015)
Proteome-wide profiling of protein assemblies by cross-linking mass spectrometry
Fan Liu et al.
NATURE METHODS (2015)
The discovery of modular binding domains: building blocks of cell signalling
Bruce J. Mayer
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Intrinsically disordered proteins in cellular signalling and regulation
Peter E. Wright et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Comprehensive assessment of cancer missense mutation clustering in protein structures
Atanas Kamburov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Quantitative interactome analysis reveals a chemoresistant edgotype
Juan D. Chavez et al.
NATURE COMMUNICATIONS (2015)
Small-Molecule Inhibitors That Target Protein-Protein Interactions in the RAD51 Family of Recombinases
Duncan E. Scott et al.
CHEMMEDCHEM (2015)
Directed evolution of APEX2 for electron microscopy and proximity labeling
Stephanie S. Lam et al.
NATURE METHODS (2015)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
A Proteome-Scale Map of the Human Interactome Network
Thomas Rolland et al.
CELL (2014)
A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia
Stefan Groeschel et al.
CELL (2014)
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Michelle R. Arkin et al.
CHEMISTRY & BIOLOGY (2014)
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
Charles Butts et al.
LANCET ONCOLOGY (2014)
Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs
Chong Wang et al.
NATURE COMMUNICATIONS (2014)
Oncogenic protein interfaces: small molecules, big challenges
Tracy L. Nero et al.
NATURE REVIEWS CANCER (2014)
Edgotype: a fundamental link between genotype and phenotype
Nidhi Sahni et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Does Chemotherapy Really Affect the Quality of Life of Women with Breast Cancer?
Sook Yeon Hwang et al.
JOURNAL OF BREAST CANCER (2013)
Latest developments in molecular docking: 2010-2011 in review
Elizabeth Yuriev et al.
JOURNAL OF MOLECULAR RECOGNITION (2013)
The 'rule of three' for fragment-based drug discovery: where are we now?
Harren Jhoti et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
D. W. Kufe
ONCOGENE (2013)
EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation
Emilie A. Bard-Chapeau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Targeting protein-protein interactions as an anticancer strategy
Andrei A. Ivanov et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium
Matthew J. Ellis et al.
CANCER DISCOVERY (2013)
Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface
Inge Van Molle et al.
CHEMISTRY & BIOLOGY (2012)
A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells
Kyle J. Roux et al.
JOURNAL OF CELL BIOLOGY (2012)
A Class of Allosteric Caspase Inhibitors Identified by High-Throughput Screening
Taya Feldman et al.
MOLECULAR CELL (2012)
The IntAct molecular interaction database in 2012
Samuel Kerrien et al.
NUCLEIC ACIDS RESEARCH (2012)
Affinity-purification coupled to mass spectrometry: Basic principles and strategies
Wade H. Dunham et al.
PROTEOMICS (2012)
Interactome Networks and Human Disease
Marc Vidal et al.
CELL (2011)
MUC1 regulates nuclear localization and function of the epidermal growth factor receptor
Benjamin G. Bitler et al.
JOURNAL OF CELL SCIENCE (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2010)
An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
Paola Cappello et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Edgetic perturbation models of human inherited disorders
Quan Zhong et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
The rise of fragment-based drug discovery
Christopher W. Murray et al.
NATURE CHEMISTRY (2009)
Brd4 recruits P-TER to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression
Zhiyuan Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces
James A. Wells et al.
NATURE (2007)
MINT: the molecular INTeraction database
Andrew Chatr-aryamontri et al.
NUCLEIC ACIDS RESEARCH (2007)
MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90
J Ren et al.
ONCOGENE (2006)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
J Ren et al.
CANCER CELL (2004)
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer
TK Oost et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma
DI Loukinov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cancer as a complex genetic trait: Tumor susceptibility in humans and mouse models
A Balmain
CELL (2002)
Multifunctional α-enolase:: its role in diseases
V Pancholi
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
分享论文
